Alfa Lafleur in Largo, Florida

Home Florida Largo

Alfa Lafleur has Nurse Practitioner as her primary medical specialty. Their primary office is: 100 Highland Ave N in Largo, Florida. There is an additional office location, for a total of two, for Alfa Lafleur that can be viewed further down.

They're a part of the: Florida Cancer Specialists And Research Institute, Llc medical group which has around 380 members. You can call their office at 727-683-2900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2009 (around 15 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Alfa Lafleur Office Phone and Directions

Alfa Lafleur
Florida Cancer Specialists And Research Institute, Llc
100 Highland Ave N
Largo, Florida 33770
727-683-2900

Patient Ratings
Please rate your experience with Alfa Lafleur below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 727-683-2900

Enter a starting address:

Healthcare Info for Alfa Lafleur

Medical School: Sorry, her university is not listed
Graduation Year: 2009
The Primary Medical Specialty for Alfa Lafleur is listed as: Nurse Practitioner
Approximate Years of Experience: 15
PAC (PECOS ID)#: 9830433457
NPI #: 1992286272
NPI Created On: 08/24/2018
NPI Last Updated Listed as: 08/24/2018
Primary Taxonomy Code: 363LF0000X
License Number:
ARNP9388439
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898447

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898449

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898451

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898453

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898455

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898459

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898457

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898461

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898463

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788898465

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Additional Office Locations

1. Florida Cancer Specialists And Research Institute, Llc
1396 Whisper Cir
Sebring, FL 33870
Group Members: 380

Phone: 727-683-2900

Enter a starting address:

Nurse Practitioner Professionals in Largo

1.
Krystal Parmar

499 Alternate Keene Rd
Largo, FL
Mobile Physician Services Inc

2.
Kerri Dolan Haire

8905 Bryan Dairy Rd
Largo, FL
Minuteclinic Llc

3.
Darelys Ruiz

300 Lake Ave Ne
Largo, FL
Mobile Physician Services Inc

4.
Laura Jones

750 Starkey Rd
Largo, FL
Coastal Premier Medical Care

5.
Daphne Gardner

1345 W Bay Dr
Largo, FL
Optumcare Florida, Llc

6.
Kyla Hargraves

3800 E Bay Dr
Largo, FL
Best Value Healthcare Llc

Providers in Florida Cancer Specialists And Research Institute, Llc

1.Patrick Acevedo Md

1503 Buenos Aires Blvd
The Villages Fl 32159-6823
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

2.Patrick Acevedo Md

6420 W Newberry Rd E Wing
Gainesville Fl 32605-4308
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

3.Patrick Acevedo Md

1396 Whisper Cir
Sebring Fl 33870-1204
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

4.Patrick Acevedo Md

2848 Ctr Pointe Dr
Fort Myers Fl 33916-9521
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

5.Patrick Acevedo Md

901 Tamiami Trl S
Venice Fl 34285-3668
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

6.Patrick Acevedo Md

2231 Hwy 44 West 203
Inverness Fl 34453-3879
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

View all 380 members of Florida Cancer Specialists And Research Institute, Llc medical group